Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,415,652
+$578,872 QoQ
Shares Held
2,014
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#2,323
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $11,215,095 across 12 Drug Manufacturers - General names. LLY ranks #1 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,014 | $2,415,652 | |
| 2 | JNJ |
Johnson & Johnson
|
6,868 | $1,744,265 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,448 | $1,342,568 | |
| 4 | NVS |
Novartis AG
|
7,947 | $1,245,453 | |
| 5 | AZN |
Astrazeneca PLC
|
5,336 | $1,011,812 | |
| 6 | AMGN |
Amgen Inc
|
2,387 | $864,380 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
5,127 | $647,745 | |
| 8 | ABBV |
AbbVie Inc.
|
2,265 | $569,964 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,415,652 | 2,014 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,836,780 | 1,997 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,145,061 | 1,996 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,636,635 | 2,145 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,676,769 | 2,151 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,766,621 | 2,139 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,643,588 | 2,129 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,904,771 | 2,150 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,940,229 | 2,143 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,648,497 | 2,119 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,225,880 | 2,103 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,145,698 | 2,133 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,000,334 | 2,133 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $739,039 | 2,152 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $773,385 | 2,114 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $689,705 | 2,133 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $697,094 | 2,150 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $612,831 | 2,140 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $590,558 | 2,138 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $496,757 | 2,150 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $479,008 | 2,087 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $382,046 | 2,045 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $340,381 | 2,016 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $291,599 | 1,970 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $335,748 | 2,045 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $267,313 | 1,927 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||